(Q40570608)

21 September 2017

title

Enhancement of antineoplastic action of 5-aza-2'-deoxycytidine by phenylbutyrate on L1210 leukemic cells (English)

1 reference

21 September 2017

1 reference

Maryse Lemaire

1

1 reference

21 September 2017

Louise F Momparler

2

1 reference

21 September 2017

Nuno Jorge Farinha

3

1 reference

21 September 2017

Mark Bernstein

4

1 reference

21 September 2017

Richard L Momparler

5

1 reference

21 September 2017

publication date

1 January 2004

1 reference

21 September 2017

1 reference

21 September 2017

volume

45

1 reference

21 September 2017

issue

1

1 reference

21 September 2017

page(s)

147-154

1 reference

Intensive postremission chemotherapy in adults with acute myeloid leukemia. Cancer and Leukemia Group B

21 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F1042819031000149304

Cancer epigenetics comes of age

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819031000149304

The language of covalent histone modifications

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819031000149304

DNA methylation and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819031000149304

Histone deacetylase inhibitors: inducers of differentiation or apoptosis of transformed cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819031000149304

Modifying histones to tame cancer: clinical development of sodium phenylbutyrate and other histone deacetylase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819031000149304

Interaction of 5-aza-2'-deoxycytidine and depsipeptide on antineoplastic activity and activation of 14-3-3sigma, E-cadherin and tissue inhibitor of metalloproteinase 3 expression in human breast carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819031000149304

Antineoplastic action of 5-aza-2'-deoxycytidine and phenylbutyrate on human lung carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819031000149304

Sequential 5-Aza-2 deoxycytidine-depsipeptide FR901228 treatment induces apoptosis preferentially in cancer cells and facilitates their recognition by cytolytic T lymphocytes specific for NY-ESO-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819031000149304

Therapeutic targeting of transcription in acute promyelocytic leukemia by use of an inhibitor of histone deacetylase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819031000149304

Histone-deacetylase inhibitors: novel drugs for the treatment of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819031000149304

Effect of 5-aza-2'-deoxycytidine and retinoic acid on differentiation and c-myc expression in HL-60 myeloid leukemic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819031000149304

Clinical trial on 5-aza-2'-deoxycytidine in patients with acute leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819031000149304

10.1080/1042819031000149304

21 January 2018

Identifiers

DOI

1 reference

21 September 2017

1 reference